Document is current
Any future updates will be listed below
-
Authors
Boyle, Patrick M.
Zghaib, Tarek
Zahid, Sohail
Ali, Rheeda L.
Deng, Dongdong
Franceschi, William H.
Hakim, Joe B.
Murphy, Michael J.
Prakosa, Adityo
Zimmerman, Stefan L. http://orcid.org/0000-0002-9422-6742
Ashikaga, Hiroshi http://orcid.org/0000-0003-3689-6892
Marine, Joseph E.
Kolandaivelu, Aravindan
Nazarian, Saman
Spragg, David D.
Calkins, Hugh
Trayanova, Natalia A. http://orcid.org/0000-0002-8661-063X
-
Funding
Funding for this research was provided by:
American Heart Association (16-SDG-30440006)
National Science Foundation (graduate fellowship)
Johnson & Johnson | Biosense Webster
Roz and Marvin H. Weiner and Family Foundation Dr. Francis P. Chiaramonte Foundation Marilyn and Christian Poindexter Norbert and Louise Grunwald Cardiac Arrhythmia Research Fund
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (DP1-HL123271, U01-HL141074)
Fondation Leducq (Research Grant number 16 CVD 02)
- License Information
-
More Information
Article History
Received: 31 August 2018
Accepted: 3 July 2019
First Online: 19 August 2019
Competing interests
: N.A.T. has filed a patent application (US patent application number US0161100A1; World Intellectual Property Organization application number WO2015/084876A1; European Patent Office application number EP3076869A4; Japan application number JP2016540570A; Israel application number IL245988D0; entitled ‘Systems and methods for atrial fibrillation treatment and risk assessment’) that is currently under review.
